Yoshimura N, Muraki S, Oka H, Mabuchi A, En-Yo Y, Yoshida M, Saika A, Yoshida H, Suzuki T, Yamamoto S, Ishibashi H, Kawaguchi H, Nakamura K, Akune T (2009) Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study. J Bone Miner Metab 27:620–628

Article  PubMed  Google Scholar 

Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G (2007) Chronic kidney disease as a global public health problem: approaches and initiatives-a position statement from kidney disease improving global outcomes. Kidney Int 72:247–259

Article  CAS  PubMed  Google Scholar 

Klawansky S, Komaroff E, Cavanaugh PF Jr, Mitchell DY, Gordon MJ, Connelly JE, Ross SD (2003) Relationship between age, renal function and bone mineral density in the US population. Osteoporos Int 14:570–576

Article  CAS  PubMed  Google Scholar 

Kazama JJ (2017) Chronic kidney disease and fragility fracture. Clin Exp Nephrol 21:46–52

Article  CAS  PubMed  Google Scholar 

Suzuki T, Yoshida H (2010) Low bone mineral density at femoral neck is a predictor of increased mortality in elderly Japanese women. Osteoporos Int 21:71–79

Article  CAS  PubMed  Google Scholar 

Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301:513–521

Article  CAS  PubMed  Google Scholar 

Cook WL, Tomlinson G, Donaldson M, Markowitz SN, Naglie G, Sobolev B, Jassal SV (2006) Falls and fall-related injuries in older dialysis patients. Clin J Am Soc Nephrol 1:1197–1204

Article  PubMed  Google Scholar 

Chesnut CH 3rd, Skag A, Christiansen C, Recker R, Stakkestad JA, Hoiseth A, Felsenberg D, Huss H, Gilbride J, Schimmer RC, Delmas PD (2004) Oral ibandronate osteoporosis vertebral fracture trial in North America and Europe (BONE). Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res 19:1241–1249

Article  CAS  PubMed  Google Scholar 

Wells G, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P (2008) Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD004523.pub3

Article  PubMed  PubMed Central  Google Scholar 

KDIGO Chronic Kidney Disease– Mineral and Bone Disorder (CKD-MBD) Guideline Update 2017. Accessed 12 May 2023

Matsumoto T, Hagino H, Shiraki M, Fukunaga M, Nakano T, Takaoka K, Morii H, Ohashi Y, Nakamura T (2009) Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study. Osteoporos Int 20:1429–1437

Article  CAS  PubMed  Google Scholar 

Tentori F, Elder SJ, Thumma J, Pisoni RL, Bommer J, Fissell RB, Fukuhara S, Jadoul M, Keen ML, Saran R, Ramirez SP, Robinson BM (2010) Physical exercise among participants in the dialysis outcomes and practice patterns study (DOPPS): correlates and associated outcomes. Nephrol Dial Transplant 25:3050–3062

Article  PubMed  Google Scholar 

Gillespie LD, Robertson MC, Gillespie WJ, Sherrington C, Gates S, Clemson LM, Lamb SE (2012) Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 12:CD007146

Google Scholar 

Kemmler W, Häberle L, von Stengel S (2013) Effects of exercise on fracture reduction in older adults: a systematic review and meta-analysis. Osteoporos Int 24:1937–1950

Article  CAS  PubMed  Google Scholar 

Mohebbi R, Shojaa M, Kohl M, von Stengel S, Jakob F, Kerschan-Schindl K, Lange U, Peters S, Thomasius F, Uder M, Kemmler W (2023) Exercise training and bone mineral density in postmenopausal women: an updated systematic review and meta-analysis of intervention studies with emphasis on potential moderators. Osteoporos Int 7:1145–1178

Article  Google Scholar 

Kanazawa M, Kawamura T, Li L, Sasaki Y, Matsumoto K, Kataoka H, Ito O, Minami N, Sato T, Ootaka T, Kohzuki M (2006) Combination of exercise and enalapril enhances renoprotective and peripheral effects in rats with renal ablation. Am J Hypertens 19:80–86

Article  CAS  PubMed  Google Scholar 

Saud A, Luiz RS, Leite APO, Muller CR, Visona I, Reinecke N, Silva WH, Gloria MA, Razvickas CV, Casarini DE, Schor N (2021) Resistance exercise training ameliorates chronic kidney disease outcomes in a 5/6 nephrectomy model. Life Sci 275:119362

Article  CAS  PubMed  Google Scholar 

Ito D, Cao P, Kakihana T, Sato E, Suda C, Muroya Y, Ogawa Y, Hu G, Ishii T, Ito O, Kohzuki M, Kiyomoto H (2015) Chronic running exercise alleviates early progression of nephropathy with upregulation of nitric oxide synthases and suppression of glycation in Zucker diabetic rats. PLoS ONE 17:e0138037

Article  Google Scholar 

Marinho SM, Moraes C, Barbosa JE, Carraro Eduardo JC, Fouque D, Pelletier S, Mafra D (2016) Exercise training alters the bone mineral density of hemodialysis patients. J Strength Cond Res 30:2918–2923

Article  PubMed  Google Scholar 

Saito H, Miyakoshi N, Kasukawa Y, Nozaka K, Tsuchie H, Sato C, Abe K, Shoji R, Shimada Y (2021) Analysis of bone in adenine-induced chronic kidney disease model rats. Osteoporos Sarcopenia 7:121–126

Article  PubMed  PubMed Central  Google Scholar 

Kinoshita H, Miyakoshi N, Kasukawa Y, Sakai S, Shiraishi A, Segawa T, Ohuchi K, Fujii M, Sato C, Shimada Y (2016) Effects of eldecalcitol on bone and skeletal muscles in glucocorticoid-treated rats. J Bone Miner Metab 34:171–178

Article  CAS  PubMed  Google Scholar 

Fujita R, Ota M, Sato D, Nakazawa D, Kimura-Suda H, Nakamura F, Shimizu T, Kobayashi H, Iwasaki N, Takahata M (2020) Comparison of the efficacy and renal safety of bisphosphonate between low-dose/high-frequency and high-dose/low-frequency regimens in a late-stage chronic kidney disease rat model. Calcif Tissue Int 107:389–402

Article  CAS  PubMed  Google Scholar 

Kohzuki M, Kamimoto M, Wu XM, Xu HL, Kawamura T, Mori N, Nagasaka M, Kurosawa H, Minami N, Kanazawa M, Saito T, Yoshida K (2001) Renal protective effects of chronic exercise and antihypertensive therapy in hypertensive rats with chronic renal failure. J Hypertens 19:1877–1882

Article  CAS  PubMed  Google Scholar 

Yamamoto S, Fukagawa M (2017) Uremic toxicity and bone in CKD. J Nephrol 30:623–627

Article  PubMed  Google Scholar 

Abe K, Miyakoshi N, Kasukawa Y, Nozaka K, Tsuchie H, Sato C, Saito H, Shoji R, Shimada Y (2022) Effects of teriparatide and low-intensity aerobic exercise on osteopenia in type 2 diabetes mellitus rats. J Bone Miner Metab 40:229–239

Article  CAS  PubMed  Google Scholar 

Miyakoshi N, Fujii M, Kasukawa Y, Shimada Y (2019) Impact of vitamin C on teriparatide treatment in the improvement of bone mineral density, strength, and quality in vitamin C-deficient rats. J Bone Miner Metab 37:411–418

Article  CAS  PubMed  Google Scholar 

Kasukawa Y, Miyakoshi N, Itoi E, Tsuchida T, Tamura Y, Kudo T, Suzuki K, Seki A, Sato K (2004) Effects of h-PTH on cancellous bone mass, connectivity, and bone strength in ovariectomized rats with and without sciatic-neurectomy. J Orthop Res 22:457–464

Article  CAS  PubMed  Google Scholar 

Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 48:452–458

Article  CAS  PubMed  Google Scholar 

Ferrari GO, Ferreira JC, Cavallari RT, Neves KR, dos Reis LM, Dominguez WV, Oliveira EC, Graciolli FG, Passlick-Deetjen J, Jorgetti V, Moysés RM (2014) Mineral bone disorder in chronic kidney disease: head-to-head comparison of the 5/6 nephrectomy and adenine models. BMC Nephrol 15:69

Article  PubMed  PubMed Central  Google Scholar 

Gordon PL, Frassetto LA (2010) Management of osteoporosis in CKD Stages 3 to 5. Am J Kidney Dis 55:941–956

Article  PubMed  Google Scholar 

Ota M, Takahata M, Shimizu T, Kanehira Y, Kimura-Suda H, Kameda Y, Hamano H, Hiratsuka S, Sato D, Iwasaki N (2017) Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemia. Osteoporos Int 28:1481–1490

Article  CAS  PubMed  Google Scholar 

Miller PD, Jamal SA, Evenepoel P, Eastell R, Boonen S (2013) Renal safety in patients treated with bisphosphonates for osteoporosis: a review. J Bone Miner Res 28:2049–2059

Article  CAS  PubMed  Google Scholar 

Miller PD, Roux C, Boonen S, Barton IP, Dunlap LE, Burgio DE (2005) Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials. J Bone Miner Res 20:2105–2115

Article  CAS  PubMed  Google Scholar 

Perazella MA, Markowitz GS (2008) Bisphosphonate nephrotoxicity. Kidney Int 74:1385–1393

Article  CAS  PubMed  Google Scholar 

Pfister T, Atzpodien E, Bauss F (2003) The renal effects of minimally nephrotoxic doses of ibandronate and zoledronate following single and intermittent intravenous administration in rats. Toxicology 191:159–167

Article  CAS  PubMed  Google Scholar 

Tufescu A, Kanazawa M, Ishida A, Lu H, Sasaki Y, Ootaka T, Sato T, Kohzuki M (2008) Combination of exercise and losartan enhances renoprotective and peripheral effects in spontaneously type 2 diabetes mellitus rats with nephropathy. J Hypertens 26:312–321

Article  CAS  PubMed